Literature DB >> 30120217

Homozygosity for the c.428delG variant in KIAA0586 in a healthy individual: implications for molecular testing in patients with Joubert syndrome.

Silke Pauli1, Janine Altmüller2, Simone Schröder3, Andreas Ohlenbusch4, Steffi Dreha-Kulaczewski4, Carsten Bergmann5, Peter Nürnberg2, Holger Thiele2, Yun Li1, Bernd Wollnik1, Knut Brockmann3.   

Abstract

BACKGROUND: Joubert syndrome (JBTS) is a rare neurodevelopmental disorder with marked phenotypic variability and genetic heterogeneity. Homozygous or compound heterozygous mutations in the KIAA0586 gene on chromosome 14q23 are known to be associated with JBTS-23. The frameshift variant c.428delG is the most frequent KIAA0586 variant reported in JBTS-23; yet, homozygosity of this variant was observed in two patients with JBTS-23. However, homozygosity of the c.428delG variant was recently reported as well in one healthy individual.
OBJECTIVE: To clarify whether the frameshift variant c.428delG in KIAA0586 is pathogenic in the homozygous state.
METHODS: Whole-exome sequencing as well as RNA analysis were performed.
RESULTS: We identified biallelic mutations, including the variant c.428delG and a splice site variant c.1413-1G>C, in KIAA0586 in two siblings with clinical and MRI features of JBTS. The c.1413-1G>C variant was inherited from the healthy father. The c.428delG variant was found in the healthy mother in a homozygous state in blood lymphocytes, hair root cells and buccal epithelial cells. RNA analysis revealed that the transcript harbouring the c.428delG variant was expressed in blood cells from the healthy mother, indicating that transcripts harbouring this variant elude the mechanism of nonsense-mediated mRNA decay.
CONCLUSION: Considering this and the high allele frequency of 0.003117 in the gnomAD database, we conclude that c.428delG represents a JBTS disease-causing variant only if present in compound heterozygous state with a more severe KIAA0586 variant, but not in a homozygous situation. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  clinical genetics; joubert syndrome; kiaa0586; neurology

Mesh:

Substances:

Year:  2018        PMID: 30120217     DOI: 10.1136/jmedgenet-2018-105470

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  4 in total

1.  Sudden death in epilepsy and ectopic neurohypophysis in Joubert syndrome 23 diagnosed using SNVs/indels and structural variants pipelines on WGS data: a case report.

Authors:  Dulika Sumathipala; Petter Strømme; Christian Gilissen; Ingunn Holm Einarsen; Hilde J Bjørndalen; Andrés Server; Jordi Corominas; Bjørnar Hassel; Madeleine Fannemel; Doriana Misceo; Eirik Frengen
Journal:  BMC Med Genet       Date:  2020-05-07       Impact factor: 2.103

2.  Update of genetic variants in CEP120 and CC2D2A-With an emphasis on genotype-phenotype correlations, tissue specific transcripts and exploring mutation specific exon skipping therapies.

Authors:  Miguel Barroso-Gil; Eric Olinger; Simon A Ramsbottom; Elisa Molinari; Colin G Miles; John A Sayer
Journal:  Mol Genet Genomic Med       Date:  2021-01-24       Impact factor: 2.473

Review 3.  Genotype-phenotype correlates in Joubert syndrome: A review.

Authors:  Simone Gana; Valentina Serpieri; Enza Maria Valente
Journal:  Am J Med Genet C Semin Med Genet       Date:  2022-03-03       Impact factor: 3.359

4.  The Israeli national population program of genetic carrier screening for reproductive purposes. How should it be continued?

Authors:  Joël Zlotogora
Journal:  Isr J Health Policy Res       Date:  2019-12-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.